'For the quarter ending March 2024, consolidated Net sales (including other operating income) of Laurus Labs has increased 4.26% to Rs 1439.67 crore compared to quarter ended March 2023. Operating profit margin has declined from 20.68% to 16.77%, leading to 15.43% decline in operating profit to Rs 241.49 crore.  Raw material cost as a % of total sales (net of stock adjustments) increased from 40.81% to 43.81%.   Purchase of finished goods cost rose from 0.42% to 3.02%.   Employee cost increased from 11.50% to 11.94%.   Other expenses rose from 22.82% to 23.34%.   

Other income rose 983.63% to Rs 18.53 crore.  PBIDT fell 9.48% to Rs 260.02 crore.  Provision for interest fell 4.90% to Rs 50.5 crore.  Loan funds rose to Rs 2,577.40 crore as of 31 March 2024 from Rs 2,015.09 crore as of 31 March 2023.  Inventories rose to Rs 1,845.41 crore as of 31 March 2024 from Rs 1,684.81 ...

• 

  (01-Mar-2025)

  Foseco India

  OP up 17%
• 

  (28-Feb-2025)

  Schaeffler India

  Maintains double digit revenue growth and stable OPM
• 

  (28-Feb-2025)

  Sanofi India

  OP up 18.78%
• 

  (28-Feb-2025)

  KSB

  Net up 33% largely on higher sales, higher OI and lower taxation